FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2887788194> ?p ?o ?g. }

• W2887788194 abstract "Identification of tumor-specific neo-antigens is crucial to developing new immunotherapeutic approaches, e.g. personalized vaccines. While computer algorithms can predict Class I or II HLA specific neoantigens, experimental confirmation of these potentially immunogenic neoantigens remains challenging, primarily due to the complexity associated with understanding the MHC-antigen and T cell receptor interaction. Here, we developed a systematic pipeline to efficiently identify immunogenic neoantigens and evaluate their immunogenicity in healthy donors. Whole-exome sequencing(WES) of a melanoma was used to identify non-synonymous mutations. MHC presentation was predicted with digital HLA typing and MHC class I allele-restricted binding affinity/stability algorithms (netMHCpan/netMHCstab). The tumor clonal architecture was identified for each peptide to prioritize clonal over subclonal neoantigens using BubbleTree (https://bioconductor.org/packages/release/bioc/html/BubbleTree.html). Immunogenicity testing was done using a novel in-vitro assay with blood from healthy HLA-A201 donors. Naive CD8 T cells were stimulated with autologous dendritic cells pulsed initially with peptide pools followed by individual peptides. The presence of antigen-specific T cells was determined via MHC-multimer staining and function was assessed by intracellular staining and IFNy EliSpot. Nonsynonymous somatic mutations (N = 205) were identified by WES from the melanoma tumor biopsy. From a library of mutated tumor-specific peptides (N = 7512), 18 candidates predicted to be Class I neo-antigens were selected for immunogenicity testing. A new in-vitro assay using blood from healthy HLA-A201 donors identified one peptide that expanded antigen-specific T cells. Analysis of this mutation showed a VAF of 29.3% and TCGA revealed that the mutation identified was unique. IFNy secretion indicated that these antigen-specific T cells produced 6-fold higher IFNy to the mutant peptide vs the wildtype peptide. Direct binding of peptide to HLA was confirmed in vitro. Interrogation of the peptide expanded T cells by TCRseq showed clonal T cell expansion in response to the peptide. Unique TCR sequences identified in these T cells were present in the original melanoma tumor biopsy but not in adjacent tissue, confirming that naive T cell donors can be used to validate neoantigens identified in cancer patients. The same TCR sequences were also identified in the peptide pool stimulated cells, suggesting that deconvolution may not be necessary to monitor neoantigen responses. Using a newly developed pipeline combining next generation sequencing, epitope and clonal prediction algorithms, as well as an in-vitro assay to screen and evaluate putative neoantigens as targets of antitumor immunity, we confirmed one predicted neo-antigen from a melanoma patient. This pipeline could allow for the efficient and rapid identification of personalized neoantigens. Citation Format: Nicholas M. Durham, Yelena Lazdun, Han Si, Todd Creasy, Brandon W. Higgs, Katie Streicher. A new pipeline to predict and confirm tumor neo-antigens [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 4677." @default.
• W2887788194 created "2018-08-22" @default.
• W2887788194 creator A5001220282 @default.
• W2887788194 creator A5009504777 @default.
• W2887788194 creator A5010463922 @default.
• W2887788194 creator A5011470254 @default.
• W2887788194 creator A5082831559 @default.
• W2887788194 creator A5088864413 @default.
• W2887788194 date "2018-07-01" @default.
• W2887788194 modified "2023-09-27" @default.
• W2887788194 title "Abstract 4677: A new pipeline to predict and confirm tumor neo-antigens" @default.
• W2887788194 doi "https://doi.org/10.1158/1538-7445.am2018-4677" @default.
• W2887788194 hasPublicationYear "2018" @default.
• W2887788194 type Work @default.
• W2887788194 sameAs 2887788194 @default.
• W2887788194 citedByCount "0" @default.
• W2887788194 crossrefType "proceedings-article" @default.
• W2887788194 hasAuthorship W2887788194A5001220282 @default.
• W2887788194 hasAuthorship W2887788194A5009504777 @default.
• W2887788194 hasAuthorship W2887788194A5010463922 @default.
• W2887788194 hasAuthorship W2887788194A5011470254 @default.
• W2887788194 hasAuthorship W2887788194A5082831559 @default.
• W2887788194 hasAuthorship W2887788194A5088864413 @default.
• W2887788194 hasConcept C147483822 @default.
• W2887788194 hasConcept C154317977 @default.
• W2887788194 hasConcept C167672396 @default.
• W2887788194 hasConcept C170627219 @default.
• W2887788194 hasConcept C188280979 @default.
• W2887788194 hasConcept C195616568 @default.
• W2887788194 hasConcept C202751555 @default.
• W2887788194 hasConcept C203014093 @default.
• W2887788194 hasConcept C207936829 @default.
• W2887788194 hasConcept C2779053233 @default.
• W2887788194 hasConcept C2780868878 @default.
• W2887788194 hasConcept C54355233 @default.
• W2887788194 hasConcept C86803240 @default.
• W2887788194 hasConceptScore W2887788194C147483822 @default.
• W2887788194 hasConceptScore W2887788194C154317977 @default.
• W2887788194 hasConceptScore W2887788194C167672396 @default.
• W2887788194 hasConceptScore W2887788194C170627219 @default.
• W2887788194 hasConceptScore W2887788194C188280979 @default.
• W2887788194 hasConceptScore W2887788194C195616568 @default.
• W2887788194 hasConceptScore W2887788194C202751555 @default.
• W2887788194 hasConceptScore W2887788194C203014093 @default.
• W2887788194 hasConceptScore W2887788194C207936829 @default.
• W2887788194 hasConceptScore W2887788194C2779053233 @default.
• W2887788194 hasConceptScore W2887788194C2780868878 @default.
• W2887788194 hasConceptScore W2887788194C54355233 @default.
• W2887788194 hasConceptScore W2887788194C86803240 @default.
• W2887788194 hasLocation W28877881941 @default.
• W2887788194 hasOpenAccess W2887788194 @default.
• W2887788194 hasPrimaryLocation W28877881941 @default.
• W2887788194 hasRelatedWork W1540832725 @default.
• W2887788194 hasRelatedWork W1546757669 @default.
• W2887788194 hasRelatedWork W2045884759 @default.
• W2887788194 hasRelatedWork W2082059373 @default.
• W2887788194 hasRelatedWork W2118364216 @default.
• W2887788194 hasRelatedWork W2155362903 @default.
• W2887788194 hasRelatedWork W2155999541 @default.
• W2887788194 hasRelatedWork W2341389609 @default.
• W2887788194 hasRelatedWork W2962760056 @default.
• W2887788194 hasRelatedWork W4213442759 @default.
• W2887788194 isParatext "false" @default.
• W2887788194 isRetracted "false" @default.
• W2887788194 magId "2887788194" @default.
• W2887788194 workType "article" @default.